ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

ClinicalTrials.gov ID: NCT06858579

Public ClinicalTrials.gov record NCT06858579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of DNTH103 In Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Study identification

NCT ID
NCT06858579
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dianthus Therapeutics
Industry
Enrollment
256 participants

Conditions and interventions

Interventions

  • Claseprubart Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 9, 2025
Primary completion
Dec 30, 2028
Completion
Dec 30, 2030
Last update posted
Apr 20, 2026

2025 – 2030

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Clinical Study Site Birmingham Alabama 35294 Recruiting
Clinical Study Site Phoenix Arizona 85028 Recruiting
Clinical Study Site Scottsdale Arizona 85251' Recruiting
Clinical Study Site Los Angeles California 90048 Recruiting
Clinical Study Site San Francisco California 94109 Recruiting
Clinical Study Site San Francisco California 94158 Recruiting
Clinical Study Site Washington D.C. District of Columbia 20007 Recruiting
Clinical Study Site Maitland Florida 32751 Recruiting
Clinical Study Site Tampa Florida 33620 Recruiting
Clinical Study Site Honolulu Hawaii 96817 Recruiting
Clinical Study Site Chicago Illinois 60611 Recruiting
Clinical Study Site Edwardsville Illinois 62025 Recruiting
Clinical Study Site Indianapolis Indiana 46202 Recruiting
Clinical Study Site Kansas City Kansas 66160 Recruiting
Clinical Study Site Burlington Massachusetts 01805 Recruiting
Clinical Study Site East Lansing Michigan 48824 Recruiting
Clinical Study Site Omaha Nebraska 68198 Recruiting
Cinical Study Site Lebanon New Hampshire 03766 Recruiting
Clinical Study Site New York New York 10021 Recruiting
Clinical Study Site New York New York 10032 Recruiting
Clinical Study Site Cincinnati Ohio 45219 Recruiting
Clinical Study Site Columbus Ohio 43221 Recruiting
Clinical Study Site Portland Oregon 97239 Recruiting
Clinical Study Site Dallas Texas 75243 Recruiting
Clinical Study Site Denton Texas 76208 Recruiting
Cinical Study Site Houston Texas 77030 Recruiting
Texas Locations Houston Texas 77054 Recruiting
Clinical Study Site Round Rock Texas 78681 Recruiting
Clinical Study Site Sugar Land Texas 77478 Recruiting
Clinical Study Site Seattle Washington 98195 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 128 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06858579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06858579 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →